Transplantation Using Hepatitis C Positive Donors, A Safety Trial
Conditions: Lung Transplant Infection; Heart Transplant Infection; Kidney Transplant Infection; Kidney Pancreas Infection; Hepatitis C Interventions: Drug: Glecaprevir 300 MG / Pibrentasvir 120 MG Oral Tablet; Drug: Ezetimibe 10Mg Oral Tablet; Device: Ex Vivo Lung Perfusion Sponsors: Jordan Feld; University Health Network, Toronto Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials